-
公开(公告)号:US20050107341A1
公开(公告)日:2005-05-19
申请号:US10983363
申请日:2004-11-08
申请人: Hans Hilpert , Roland Humm , Dietmar Knopp , Peter Weiss
发明人: Hans Hilpert , Roland Humm , Dietmar Knopp , Peter Weiss
IPC分类号: C07F9/30 , C07F9/572 , C07F9/58 , C07F9/60 , C07F9/653 , A61K31/675 , A61K31/661 , C07F9/141
摘要: The present invention relates to phosphinic acid derivatives of formula I wherein R1, R2, R3 and R4 are described hereinabove. These compounds can be used in the treatment or prevention of a disease related to the inhibition of β-secretase, inter alia for the treatment of Alzheimer's disease.
摘要翻译: 本发明涉及式Ⅰ的次膦酸衍生物,其中R 1,R 2,R 3和R 4, >如上所述。 这些化合物可用于治疗或预防与β-分泌酶的抑制相关的疾病,特别是用于治疗阿尔茨海默氏病。
-
公开(公告)号:US07345082B2
公开(公告)日:2008-03-18
申请号:US10983363
申请日:2004-11-08
申请人: Hans Hilpert , Roland Humm , Dietmar Knopp , Peter Weiss
发明人: Hans Hilpert , Roland Humm , Dietmar Knopp , Peter Weiss
IPC分类号: A61K31/405 , C07F9/02
摘要: The present invention relates to phosphinic acid derivatives of formula I wherein R1, R2, R3 and R4 are described hereinabove. These compounds can be used in the treatment or prevention of a disease related to the inhibition of β-secretase, inter alia for the treatment of Alzheimer's disease.
摘要翻译: 本发明涉及式I的次膦酸衍生物,其中R 1,R 2,R 3和R 4, >如上所述。 这些化合物可用于治疗或预防与β-分泌酶的抑制相关的疾病,特别是用于治疗阿尔茨海默氏病。
-
公开(公告)号:US20060106016A1
公开(公告)日:2006-05-18
申请号:US11263497
申请日:2005-10-31
申请人: Markus Boehringer , Katrin Zbinden , Wolfgang Haap , Hans Hilpert , Jacques Himber , Roland Humm , Hans Iding , Dietmar Knopp , Narendra Panday , Fabienne Ricklin , Christoph Stahl
发明人: Markus Boehringer , Katrin Zbinden , Wolfgang Haap , Hans Hilpert , Jacques Himber , Roland Humm , Hans Iding , Dietmar Knopp , Narendra Panday , Fabienne Ricklin , Christoph Stahl
IPC分类号: A61K31/5377 , A61K31/497 , A61K31/4747 , A61K31/44 , C07D413/02 , C07D403/02
CPC分类号: C07D213/64 , C07D213/75 , C07D233/64 , C07D279/02 , C07D295/135 , C07D295/185 , C07D401/12
摘要: The invention is concerned with novel dicarboxamide derivatives of formula (I) wherein A, B, Rc, D and E are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds inhibit the coagulation factor Xa and can be used as medicaments.
摘要翻译: 本发明涉及式(I)的新型二甲酰胺衍生物,其中A,B,R c,D和E如说明书和权利要求书中所定义,以及其生理上可接受的盐。 这些化合物抑制凝血因子Xa,并且可以用作药物。
-
公开(公告)号:US20090270360A1
公开(公告)日:2009-10-29
申请号:US12354953
申请日:2009-01-16
申请人: Markus Boehringer , Katrin Groebke Zbinden , Wolfgang Haap , Hans Hilpert , Jacques Himber , Roland Humm , Hans Iding , Dietmar Knopp , Narendra Panday , Fabienne Ricklin , Christoph Martin Stahl
发明人: Markus Boehringer , Katrin Groebke Zbinden , Wolfgang Haap , Hans Hilpert , Jacques Himber , Roland Humm , Hans Iding , Dietmar Knopp , Narendra Panday , Fabienne Ricklin , Christoph Martin Stahl
IPC分类号: A61K31/4427 , C07D213/64 , A61K31/4418 , A61K31/444 , C07D265/32 , C07D279/02 , A61K31/5377 , A61K31/55 , C07D413/02 , A61K31/54 , A61K31/5375 , A61K31/506 , C07D401/02 , C07D405/02
CPC分类号: C07D213/64 , C07D213/75 , C07D233/64 , C07D279/02 , C07D295/135 , C07D295/185 , C07D401/12
摘要: The invention is concerned with novel dicarboxamide derivatives of formula (I) wherein A, B, Rc, D and E are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds inhibit the coagulation factor Xa and can be used as medicaments.
摘要翻译: 本发明涉及式(I)的新型二甲酰胺衍生物,其中A,B,Rc,D和E如说明书和权利要求书中所定义,以及其生理上可接受的盐。 这些化合物抑制凝血因子Xa,并且可以用作药物。
-
公开(公告)号:US07501413B2
公开(公告)日:2009-03-10
申请号:US11263497
申请日:2005-10-31
申请人: Markus Boehringer , Katrin Groebke Zbinden , Wolfgang Haap , Hans Hilpert , Jacques Himber , Roland Humm , Hans Iding , Dietmar Knopp , Narendra Panday , Fabienne Ricklin , Christoph Martin Stahl
发明人: Markus Boehringer , Katrin Groebke Zbinden , Wolfgang Haap , Hans Hilpert , Jacques Himber , Roland Humm , Hans Iding , Dietmar Knopp , Narendra Panday , Fabienne Ricklin , Christoph Martin Stahl
IPC分类号: C07D413/02 , C07D401/02 , A61K31/44
CPC分类号: C07D213/64 , C07D213/75 , C07D233/64 , C07D279/02 , C07D295/135 , C07D295/185 , C07D401/12
摘要: The invention is concerned with novel dicarboxamide derivatives of formula (I) wherein A, B, Rc, D and E are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds inhibit the coagulation factor Xa and can be used as medicaments.
摘要翻译: 本发明涉及式(I)的新型二甲酰胺衍生物,其中A,B,Rc,D和E如说明书和权利要求书中所定义,以及其生理上可接受的盐。 这些化合物抑制凝血因子Xa,并且可以用作药物。
-
-
-
-